Variant report
Variant | esv3323946 |
---|---|
Chromosome Location | chr8:20361197-20364045 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:20359613..20362385-chr8:20365022..20367728,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201238237 | chr8:20361197-20361198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs59387165 | chr8:20361200-20361201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs57212092 | chr8:20361210-20361211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72049297 | chr8:20361220-20361221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78049710 | chr8:20361221-20361222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs57224040 | chr8:20361222-20361223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560172904 | chr8:20361247-20361248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562248231 | chr8:20361300-20361301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11782109 | chr8:20361303-20361304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77042195 | chr8:20361314-20361315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551983077 | chr8:20361350-20361351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368875731 | chr8:20361388-20361389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7823028 | chr8:20361431-20361432 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs73609316 | chr8:20361444-20361445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549516265 | chr8:20361450-20361451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368175036 | chr8:20361461-20361462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374253560 | chr8:20361464-20361465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs369009631 | chr8:20361466-20361467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs367809817 | chr8:20361468-20361469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371485883 | chr8:20361469-20361470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs374450519 | chr8:20361473-20361474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368544181 | chr8:20361478-20361479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs71222152 | chr8:20361490-20361491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529137677 | chr8:20361585-20361586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189427648 | chr8:20361591-20361592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs548115965 | chr8:20361592-20361593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370756295 | chr8:20361622-20361623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs180777519 | chr8:20361645-20361646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565940084 | chr8:20361678-20361679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150954411 | chr8:20361680-20361681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557982247 | chr8:20361703-20361704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183513491 | chr8:20361706-20361707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189553474 | chr8:20361738-20361739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7823495 | chr8:20361751-20361752 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs7823499 | chr8:20361763-20361764 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs541721273 | chr8:20361768-20361769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553850281 | chr8:20361786-20361787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571936372 | chr8:20361804-20361805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs7828340 | chr8:20361896-20361897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564027998 | chr8:20361920-20361921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143237857 | chr8:20361957-20361958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376416082 | chr8:20361958-20361959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs11415923 | chr8:20361964-20361965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs398038532 | chr8:20361967-20361968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372304135 | chr8:20361968-20361969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140698727 | chr8:20361981-20361982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs377189267 | chr8:20362084-20362085 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145900087 | chr8:20362094-20362095 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561524497 | chr8:20362122-20362123 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
50 | rs529197594 | chr8:20362208-20362209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:20353400-20363800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr8:20359400-20365000 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
3 | chr8:20359800-20362000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr8:20359800-20364000 | Weak transcription | H1 Cell Line | embryonic stem cell |
5 | chr8:20359800-20364200 | Weak transcription | H9 Cell Line | embryonic stem cell |
6 | chr8:20360000-20363400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
7 | chr8:20360200-20364000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
8 | chr8:20360200-20364000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
9 | chr8:20360200-20364200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
10 | chr8:20360800-20361200 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
11 | chr8:20361000-20365000 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
12 | chr8:20362000-20362200 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr8:20362200-20365400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr8:20363400-20365200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr8:20363800-20365400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr8:20363800-20365400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr8:20363800-20367600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr8:20364000-20364600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
19 | chr8:20364000-20364800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
20 | chr8:20364000-20365000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
21 | chr8:20364000-20366800 | Enhancers | H1 Cell Line | embryonic stem cell |